|
Guardsman Scientific Vies for Top Technology Title at Sold-Out Forum
Park City-based Heart Failure Technology Company Among 90 Selected for Global Showcase
WBT2010
ARLINGTON, Texas--(BUSINESS WIRE)--Guardsman Scientific was among the over 90 top technology innovators from across the nation and around the world competing in Arlington, Texas, March 16-17 for top honors at WBT2010 presented by Lockheed Martin.
Guardsman’s non-invasive technology, which reduces the stress on the heart of the baby-boomers during surgery, was rigorously screened and mentored by WBT commercialization experts to present to a sold-out WBT2010 audience of over 600 participants including venture capital investors, federal agencies and licensees.
“The word is out that for investors, federal agencies and licensees seeking emerging technology opportunities, WBT offers the best deal flow in the nation,” said Paul Huleatt, WBT’s CEO. “We look forward to watching the progress of our WBT2010 presenters.”
According to Mr. Huleatt, approximately 1/3 of past WBT presenters have gone on to secure venture capital or a licensing/strategic partnering agreement. To date, past presenters have raised over $450 million in first (or next) round venture capital.
“Perioperative congestive heart failure translates into increased length of stay and readmission to hospitals after non-cardiac surgery, an unnecessary multi-billion dollar expense for the healthcare system. WBT2010 represented a unique opportunity for us to discuss our low-cost and widely applicable solution with high quality potential partners,” said Daniel P. Vezina, MD, President and CEO of Guardsman Scientific.
Mr. Huleatt highlighted that the companies groomed to present at WBT leave with new knowledge and contacts to take their technologies to market and beyond.
Guardsman is already discussing with investors for their upcoming round of financing.
ABOUT GUARDSMAN SCIENTIFIC
Guardsman Scientific, Inc. is a medical device company developing innovative solutions to address perioperative congestive heart failure (CHF). Guardsman technology is comprised of a proprietary clinical solution as well as hardware and software components. The GS solution, the EGAM/EGHEM UC SystemTM uses non-invasive ultrasound-generated data points to manage the cardiovascular needs of CHF patients undergoing non-cardiac surgical procedures and therefore reduce their length of stay in the hospital as well as readmission after discharge.
About WBTshowcase
Since 2002, the WBT has showcased over 470 technologies and emerging companies that have subsequently raised over $450 million in capital or licensed their technologies. For additional information and to register, visit www.WBTshowcase.com.
Media Contact:
Patti D. Hill
Penman PR
512.218.0401
patti@penmanpr.com
|